Data demonstrate that BRII-179 (VBI-2601) induced both B cell (antibody) and T cell responses in chronically-infected hepatitis B (HBV) patients, and was well-tolerated with no safety signals observed ...
The ability of A2-derived HBV vaccines to protect against non-A2 HBV genotypes has recently been brought into question following the publication of a study of 3.7 million blood donors in the USA. [25] ...
Engerix-B (hepatitis B vaccine [recombinant]) is a prescription vaccine that’s used to help prevent hepatitis B. Engerix-B comes as a liquid suspension for intramuscular injection. Engerix-B is used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results